"Drug trials" trang 1 - tải miễn phí từ tailieunhanh
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials

Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
8    82    1
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials

Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials
15    85    0
Post-progression treatment in cancer randomized trials: A cross-sectional study of trials leading to FDA approval and published trials between 2018 and 2020

Post-progression treatment in cancer randomized trials: A cross-sectional study of trials leading to FDA approval and published trials between 2018 and 2020
10    4    1
Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy

Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy
6    57    1
Learning disease relationships from clinical drug trials

Learning disease relationships from clinical drug trials
11    1    1
Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: A metaepidemiological investigation

Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: A metaepidemiological investigation
10    77    0
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy

Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy
11    43    1
Food and Drug Administration approvals in phase 3 Cancer clinical trials

Food and Drug Administration approvals in phase 3 Cancer clinical trials
6    69    1
Ebook Cardiac drug therapy (8th/ed): Part 2

Ebook Cardiac drug therapy (8th/ed): Part 2
470    6    1
The design, analysis and application of mouse clinical trials in oncology drug development

The design, analysis and application of mouse clinical trials in oncology drug development
14    83    0
Fool’s gold, lost treasures, and the randomized clinical trial

Fool’s gold, lost treasures, and the randomized clinical trial
19    51    1
From clinical trials to clinical practice: How long are drugs tested and then used by patients?

From clinical trials to clinical practice: How long are drugs tested and then used by patients?
5    1    1
Umbrella review of basket trials testing a drug in tumors with actionable genetic biomarkers

Umbrella review of basket trials testing a drug in tumors with actionable genetic biomarkers
8    8    1
Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
10    81    0
Adverse drug events observed in patients with type 2 diabetes mellitus treated with 100 mg versus 300 mg canagliflozin: A systematic review and meta-analysis of published randomized controlled trials

Adverse drug events observed in patients with type 2 diabetes mellitus treated with 100 mg versus 300 mg canagliflozin: A systematic review and meta-analysis of published randomized controlled trials
12    72    0
Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
11    58    1
Update on the drug treatment of hypertension: Perspectives in clinical pharmacology

Update on the drug treatment of hypertension: Perspectives in clinical pharmacology
8    1    1
PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an inclusion criterion? (PREDIT model)

PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an inclusion criterion? (PREDIT model)
8    69    1
Visualizing the dynamics of genetic profile in breast cancer treatment: A better way to explain why a drug could be repurposed: A riview

Visualizing the dynamics of genetic profile in breast cancer treatment: A better way to explain why a drug could be repurposed: A riview
13    93    0
Báo cáo y học:

Báo cáo y học: "Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development"
6    48    0